跳至主要内容
临床试验/NCT03495557
NCT03495557已完成4 期

Evaluation of Port Site Hernia Prevalence After Prophylactic Mesh Placement Following Laparoscopic Cholecystectomy: Randomized Clinical Trial

Hospital de Mataró2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
200
试验地点
2
主要终点
Umbilical trocar site hernia incidence

研究概览

简要总结

A prophylactic mesh fixation after fascial closure in umbilical trocar after cholecystectomy may prevent the trocar site hernia incidence. Especially in patients who present certain risk factors.

详细描述

Randomized controlled trial. Patients with more than two incisional hernia risk factors (age ≥70, BMI ≥30, diabetes mellitus, fascial enlargement) who undergo elective/emergent cholecystectomy. Control arm: fascial closure with simple PDS 2/0 Stitches. Study arm: fascial closure with simple PDS 2/0 stitches and onlay polypropylene mesh placement. Main outcome umbilical trocar site hernia incidence during a 3 years follow up. Clinical and radiological assessment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years
  • Laparoscopic cholecystectomy
  • Emergent/elective
  • ≥2 risk factors: diabetes mellitus, age ≥70 years, BMI ≥30, fascial enlargement

排除标准

  • Conversion to laparotomy
  • Emergent re intervention
  • Immunosuppression
  • Umbilical hernia

结局指标

主要结局

Umbilical trocar site hernia incidence

时间窗: 3 years

Umbilical trocar site hernia incidence after 6 months and 1 year (clinical assessment) and after 3 years (radiological confirmation)

次要结局

  • Seroma incidence(6 months)
  • Hematoma incidence(6 months)
  • Wound infection incidence(6 months)
  • Pain presence(6 months, 1 and 3 years)
  • Hospital discharge(48 hours)
  • Return to regular activity(6 months)
  • Surgeon satisfaction(3 years)
  • Operative time(2 hours)
  • Patient satisfaction(3 years)

研究者

发起方
Hospital de Mataró
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ana Ciscar

MD

Hospital de Mataró

研究点 (2)

Loading locations...

相似试验